This is a routine annual shareholder meeting. Monitor for any unexpected developments in the meeting minutes or subsequent filings, but no immediate trading action is warranted.
Price Chart
Executive Summary
LB Pharmaceuticals Inc. is holding its 2026 Annual Meeting of Stockholders to vote on two main proposals: electing three Class I director nominees and ratifying BDO USA, P.C. as the independent registered public accounting firm for 2026. This is a routine annual shareholder meeting with no activist involvement or contentious issues.
Key Financial Metrics
Key Facts
- The meeting is scheduled for June 3, 2026, to be held virtually.
- Three nominees are up for election to the Class I director positions: Robert A. Lenz M.D., Ph.D., Rebecca Luse, and Ran Nussbaum.
- Shareholders are asked to ratify BDO USA, P.C. as the independent registered public accounting firm for fiscal year 2026.
- The filing is a definitive proxy statement (DEFA14A) issued by the company itself (Registrant).
Financial Impact
No immediate financial impact; this is a standard governance filing.
Risk Factors
- Minimal risk; standard corporate governance process.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001193125-26-173708 |
| Document: 0001193125-26-173708-index-headers.html | 0001193125-26-173708 |
| Document: 0001193125-26-173708-index.html | 0001193125-26-173708 |
| Document: 0001193125-26-173708.txt | 0001193125-26-173708 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | SC 13G/A | $34.79 | awaiting T+60 | — | $39.56 (+13.71%) |
Oct 6, 2026 21d ago | EFFECT | $34.26 | awaiting T+60 | — | $39.56 (−15.47%) |
Sep 15, 2026 6w ago | 8-K | $43.04 | awaiting T+60 | — | $39.56 (−8.09%) |
Sep 3, 2026 7w ago | 8-K | $47.52 | awaiting T+60 | — | $39.56 (−16.75%) |
Aug 11, 2026 11w ago | 8-K | $45.33 | awaiting T+60 | — | $39.56 (−12.73%) |
Aug 11, 2026 11w ago | Press Release | $45.33 | awaiting T+60 | — | $39.56 (−12.73%) |
Jul 29, 2026 12w ago | 8-K | $39.00 $39.42 | ▲ +1.08% | ▼ −3.65% | $39.56 (+1.44%) |
Jul 22, 2026 13w ago | 8-K | $35.84 $36.69 | ▲ +2.37% | ▼ −0.89% | $39.56 (+10.38%) |
Jul 22, 2026 13w ago | Press Release | $35.84 $36.69 | ▲ +2.37% | ▼ −0.89% | $39.56 (+10.38%) |
Jun 10, 2026 19w ago | 8-K | $28.54 | awaiting T+60 | — | $39.56 (+38.61%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers